Parecoxib as an Alternative in COX-2 Hypersensitivity
The group of non-steroidal anti-inflammatory drugs (NSAIDs) is commonly involved in hypersensitivity reactions. In clinical practice the physician is often faced with the need to choose an alternative anti-inflammatory agent for a patient who has suffered a hypersensitivity reaction to a NSAID. The...
Saved in:
Published in | International journal of immunopathology and pharmacology Vol. 21; no. 1; pp. 233 - 235 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.01.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The group of non-steroidal anti-inflammatory drugs (NSAIDs) is commonly involved in hypersensitivity reactions. In clinical practice the physician is often faced with the need to choose an alternative anti-inflammatory agent for a patient who has suffered a hypersensitivity reaction to a NSAID. The most common approach to choosing the safest NSAID is to perform a challenge test. Parecoxib is the first injectable COX-2 selective inhibitor indicated for the treatment of acute postoperative pain. The authors report the case of a patient with a history of cutaneous adverse reactions to different classes of NSAIDs, including selective COX-2 inhibitors, who underwent and tolerated challenge with parecoxib. |
---|---|
ISSN: | 0394-6320 2058-7384 |
DOI: | 10.1177/039463200802100127 |